SUBSCRIBE
SUBSCRIBE

Carisma Therapeutics

NEWS
Biotech Vets Launch Arrakis With $38 Million and Will be Helmed By Biogen Alum Michael Gilman
Business
Up and Coming Scientist Gets Funding for CAR-T Startup CARMA Therapeutics
June 12, 2017
 · 
2 min read
Load More
AWARDS
  • NextGen Class of 2018
JOBS
IN THE PRESS
Business
Carisma Therapeutics Announces Changes to its Board of Directors
April 1, 2024
 · 
3 min read
Pharm Country
Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting
March 21, 2024
 · 
3 min read
Pharm Country
Carisma Therapeutics to Participate in TD Cowen’s 44th Annual Health Care Conference
February 28, 2024
 · 
1 min read
Pharm Country
Carisma Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 21, 2023
 · 
1 min read
Business
First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration
December 14, 2023
 · 
5 min read
FDA
Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte
November 28, 2023
 · 
6 min read
Pharm Country
Carisma Therapeutics to Participate in Evercore ISI HealthCONx Conference
November 22, 2023
 · 
3 min read
Business
Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
November 9, 2023
 · 
12 min read
Business
Carisma Presents Pre-Clinical Proof of Concept for in vivo CAR-M using mRNA platform in collaboration with Moderna at SITC
October 31, 2023
 · 
6 min read
Pharm Country
Carisma Therapeutics to Present at Upcoming Investor Conferences
September 5, 2023
 · 
4 min read
Load More